Adverse event totals24

The totals the trial posted for each group.

1 to 20 of 24

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo
Total, all-cause mortality	Volixibat 5 mg BID
Total, all-cause mortality	Volixibat 10 mg QD
Total, all-cause mortality	Volixibat 20 mg QD
Total, all-cause mortality	Volixibat 2-5-10-20 mg QD
Total, all-cause mortality	Volixibat 30 mg QD
Total, all-cause mortality	Volixibat 40 mg QD
Total, all-cause mortality	Volixibat 80-40-20 mg QD
Total, other adverse events	Placebo	13	21
Total, other adverse events	Volixibat 5 mg BID	9	9
Total, other adverse events	Volixibat 10 mg QD	9	9
Total, other adverse events	Volixibat 20 mg QD	9	9
Total, other adverse events	Volixibat 2-5-10-20 mg QD	9	9
Total, other adverse events	Volixibat 30 mg QD	9	9
Total, other adverse events	Volixibat 40 mg QD	9	9
Total, other adverse events	Volixibat 80-40-20 mg QD	9	9
Total, serious adverse events	Placebo	0	21
Total, serious adverse events	Volixibat 5 mg BID	0	9
Total, serious adverse events	Volixibat 10 mg QD	0	9
Total, serious adverse events	Volixibat 20 mg QD	0	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02287779/event-totals